Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting No phase listed Observational

Can Escalation Reduce Acute Myocardial Infarction Mortality in Cardiogenic Shock

ClinicalTrials.gov ID: NCT05800951

Public ClinicalTrials.gov record NCT05800951. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 19, 2026, 3:36 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Can Escalation Reduce Acute Myocardial Infarction Mortality in Cardiogenic Shock (CERAMICS Study)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The CERAMICS study is designed to more clearly delineate the current care of acute myocardial infarction with cardiogenic shock (AMICS) patients who are treated with mechanical circulatory support (MCS) devices in the United States with significant experience in MCS, all of whom have the capability of MCS escalation on-site. Study enrollment is targeted at 120 patients at 20 hospital sites, evaluating clinical outcomes, and focusing on outcomes MCS escalation decision making and ICU level management.

Study identification

NCT ID
NCT05800951
Recruitment status
Active, not recruiting
Study type
Observational
Phase
Not listed
Lead sponsor
Henry Ford Health System
Other
Enrollment
124 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 22, 2022 (Actual)
Primary completion
Dec 31, 2026 (Estimated)
Completion
Dec 31, 2026 (Estimated)
Last update posted
Apr 17, 2026

2022 – 2026

United States locations

U.S. sites
17
U.S. states
11
U.S. cities
15
Facility City State ZIP Site status
Loma Linda University Medical Center Loma Linda California 92354 —
Ronald Reagan UCLA Medical Center Los Angeles California 90095 —
Providence St. Joseph Hospital Orange Orange California 92868 —
St. Anthony Hospital Lakewood Colorado 80228 —
George Washington University Hospital Washington D.C. District of Columbia 20037 —
Northside Hospital Atlanta Atlanta Georgia 30342 —
St. Elizabeth Edgewood Hospital Edgewood Kentucky 41017 —
Henry Ford Hospital Detroit Michigan 48202 —
Ascenion St. John Hospital Detroit Michigan 48236 —
Spectrum Health Hospitals Fred and Lena Meijer Heart Center Grand Rapids Michigan 49503 —
Hackensack Meridian Jersey Shore University Medical Center Neptune City New Jersey 07753 —
Lehigh Valley Hospital-Cedar Crest Allentown Pennsylvania 18103 —
Fort Sanders Regional Medical Center Knoxville Tennessee 37916 —
TriStar Centennial Medical Center Nashville Tennessee 37203 —
Parkwest Medical Center Nashville Tennessee 37923 —
Methodist Hospital San Antonio Texas 78229 —
UVA University Hospital Charlottesville Virginia 22903 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05800951, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 17, 2026 · Synced Oct 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05800951 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →